<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高解释</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250321101054&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome<description>心血管高额外版：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250321101054&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>星期五，2025年3月21日14:10:55 +0000</lastbuilddate><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>单剂量减少标准的AF患者的Apixaban结局：Aspire 1年结果</title><link/>https://pubmed.ncbi.nlm.nih.gov/40113236/？ 08114047＆ff = 202503211054＆v = 2.18.0.post9+e462414<description>结论：在AF的韩国患者中，与剂量降低的剂量降低标准相比，剂量降低的剂量apixaban与标准标准剂量相比没有显着差异。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR J Cardiovasc药房。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：这项研究使用了前瞻性队列，评估了标签不剂量apixaban的有效性和安全性与心房颤动（AF）患者的标签剂量相对于单剂量减少标准的患者的有效性和安全性。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：在韩国脆弱的患者（ASPIRE）研究中，Apixaban在现实世界中的效果和安全性是涉及AF患者的多中心，符合单一剂量的AP患者的AF患者，将其降低了apixaban。中风/全身栓塞（SSE）和主要的安全结果是1 944例患者（平均年龄74.3±7.9岁，56％），997（51％）（51％）接受了标签外的剂量降低剂量apixaban较高的剂量较高的剂量。在随访（1。0±0.2年）期间，原油发生率SSE的率为0.9 vs. 0.7，在标签上与标签非标签组的大量出血为0.5 vs. 1.0。 35，p = 0.578）与标签标准剂量相比团体。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：在AF的韩国患者中，与剂量降低的剂量降低标准相比，剂量降低的剂量apixaban与标准标准剂量相比没有显着差异。</p><p style="color: lightgray"> PMID <a href=https://doi.org/10.1093/ehjcvp/pvaf018>：</a> <a href="https://pubmed.ncbi.nlm.nih.gov/40113236/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40113236</a> |</p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40113236</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> So-Ryoung Lee</dc:creator><dc:creator> Jungmin Choi</dc:creator><dc:creator>很快</dc:creator><dc:creator>Hyo-Jeong Ahn</dc:creator><dc:creator> Kyung-Yeon Lee</dc:creator><dc:creator> Jong-il Choi</dc:creator><dc:creator>演唱李</dc:creator><dc:creator>Jung Ho Heo</dc:creator><dc:creator>我的Young哦</dc:creator><dc:creator>年轻的Keun继续</dc:creator><dc:creator>嘿tae yu</dc:creator><dc:creator> Kwang-no Lee</dc:creator><dc:creator> Nam-Ho Kim</dc:creator><dc:creator> Hyung Wook公园</dc:creator><dc:creator>Ki Hong Lee</dc:creator><dc:creator> Seung Yong Shin</dc:creator><dc:creator> Hyoung-Seob公园</dc:creator><dc:creator>Seongwook Han</dc:creator><dc:creator> Seir哦</dc:creator><dc:creator>Gregory YH嘴唇</dc:creator><dc:creator>钟公园</dc:creator><dc:creator>Eue-Keun Choi</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>单剂量减少标准的AF患者的Apixaban结局：Aspire 1年结果</dc:title><dc:identifier>PMID：40113236</dc:identifier><dc:identifier> doi：10.1093/ehjcvp/pVAF018</dc:identifier></item><item><title>繁殖过程中母肠的生长</title><link/>https://pubmed.ncbi.nlm.nih.gov/40112802/？ 08114047＆ff = 202503211054＆v = 2.18.0.post9+e462414<description>许多雌性动物的器官使用小鼠肠道进行了重塑，这是一个醒目的和可拖动的器官，我们发现生殖重塑是预期的，并且与饮食或微生物诱导的饮食相关性均与繁殖的相关性相关性较小。和加速肠迁移确认... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月14日， <b>Cell</b> 。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">许多雌性动物的器官使用小鼠肠道进行了重塑，这是一个醒目的和可拖动的器官，我们发现生殖重塑是预期的，并且与饮食或微生物诱导的饮食相关性均与繁殖的相关性相关性较小。和加速肠迁移将SGLT3A的诱导剂诱导在肠道细胞的一个子集中，作为早期的生殖标志。预期物理器官重塑的特异性表明可以利用器官和特异性的增长计划来改善妊娠结局或防止这种增长的适应不良后果。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40112802/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40112802</a> <a href=https://doi.org/10.1016/j.cell.2025.02.015>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40112802</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Tomotsune ameku</dc:creator><dc:creator>安娜·拉达奇（Anna Laddach）</dc:creator><dc:creator>汉娜·贝克维斯（Hannah Beckwith）</dc:creator><dc:creator>亚历山德拉·米罗纳（Alexandra Milona）</dc:creator><dc:creator>洛兰兹·罗杰斯（Loranzie s Rogers）</dc:creator><dc:creator> Cornelia Schwayer</dc:creator><dc:creator>艾玛·奈（Emma Nye）</dc:creator><dc:creator> Iain r坚强</dc:creator><dc:creator>让·路易斯·托马斯（Jean-Louis Thoumas）</dc:creator><dc:creator> Umesh Kumar Gautam</dc:creator><dc:creator> Yi-fang王</dc:creator><dc:creator>Shreya Jha</dc:creator><dc:creator> Alvaro Castano-Medina</dc:creator><dc:creator>克里斯托弗·阿穆达（Christopher Amourda）</dc:creator><dc:creator> Patric M Vaelli</dc:creator><dc:creator> Sira Gevers</dc:creator><dc:creator> Elaine E Irvine</dc:creator><dc:creator>利亚·迈耶</dc:creator><dc:creator>伊万·安德鲁</dc:creator><dc:creator>Ka Lok Choi</dc:creator><dc:creator>巴维克·帕特尔（Bhavik Patel）</dc:creator><dc:creator>爱丽丝·弗朗西斯（Alice J Francis）</dc:creator><dc:creator>克里斯·斯图德（Chris Studd）</dc:creator><dc:creator>劳伦斯游戏</dc:creator><dc:creator>乔治·杨</dc:creator><dc:creator>凯文·G·墨菲（Kevin G Murphy）</dc:creator><dc:creator>布林·欧文</dc:creator><dc:creator>多米尼克·J·威瑟斯（Dominic J Withers）</dc:creator><dc:creator>玛丽亚·罗德里格斯·科尔曼（Maria Rodriguez-Colman）</dc:creator><dc:creator>海伦·科克斯</dc:creator><dc:creator>Prisca Liberali</dc:creator><dc:creator>马丁·施瓦泽（Martin Schwarzer）</dc:creator><dc:creator> FrançoisLeulier</dc:creator><dc:creator> Vassilis Pachnis</dc:creator><dc:creator>尼古拉斯W贝洛诺</dc:creator><dc:creator>艾琳·米格尔·阿里亚加（Irene Miguel-Aliaga）</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>细胞</dc:source><dc:title>繁殖过程中母肠的生长</dc:title><dc:identifier>PMID：40112802</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.015</dc:identifier></item><item><title>人类免疫细胞中的亚洲多样性</title><link/>https://pubmed.ncbi.nlm.nih.gov/40112801/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description>人类多样性与生物医学表型的关系无处不在，尤其是在单细胞基因组中，我们提出了亚洲免疫多样性Atlas（AIDA），这是一个多国单细胞RNA RNA测序（SCRNA-SCRNA-Seq）的健康群体。 5个亚洲国家，和6个对照组。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月18<b>日</b>：0092-8674（25）00202-8：10.1016/j.cell.2025.02.017。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">人类多样性与生物医学表型的关系无处不在，尤其是在单细胞基因组中，我们提出了亚洲免疫多样性Atlas（AIDA），这是一个多国单细胞RNA RNA测序（SCRNA-SCRNA-Seq）的健康群体。 5个亚洲国家，虽然6个对照组在连续的水平上进行比较，但我们发现次生的多样性，年龄和性别影响的细胞和分子特性，这些细胞邻居的差异包括疾病的风险，病原体和诊断，包括细胞种群和基因。在非亚洲人群中的代表性不足，并有助于与疾病相关的变体进行情境化。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40112801/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40112801</a> <a href=https://doi.org/10.1016/j.cell.2025.02.017>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40112801</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator>基恩·洪科克（Kian Hong Kock）</dc:creator><dc:creator> Le Min Tan</dc:creator><dc:creator> Kyung Yeon Han</dc:creator><dc:creator> Yoshinari Ando</dc:creator><dc:creator> Damita Jevapatarakul</dc:creator><dc:creator> Ankita Chatterjee</dc:creator><dc:creator> Quy Xiao Xuan lin</dc:creator><dc:creator> Eliora vialain buyamin</dc:creator><dc:creator> Radhika Sonthalia</dc:creator><dc:creator> Deepa Rajagopalan</dc:creator><dc:creator> Yoshihiko Tomofuji</dc:creator><dc:creator> Shvetha Sankaran</dc:creator><dc:creator> Mi-so公园</dc:creator><dc:creator>麦安德晋三</dc:creator><dc:creator>Juthamard Chantaraamporn</dc:creator><dc:creator>精人Furukawa</dc:creator><dc:creator> Supratim Ghosh</dc:creator><dc:creator>陀螺</dc:creator><dc:creator>Miki Kojima</dc:creator><dc:creator> Tsukasa Kouno</dc:creator><dc:creator>金林·林</dc:creator><dc:creator>Keiko Myuzen</dc:creator><dc:creator> Sarintip Nguantad</dc:creator><dc:creator> Jin-Mi哦</dc:creator><dc:creator>Nirmala Arul Rayan</dc:creator><dc:creator> Sumanta Sarkar</dc:creator><dc:creator> Akari Suzuki</dc:creator><dc:creator> Narita Thungsatianpun</dc:creator><dc:creator> Prasanna Nori Venkatesh</dc:creator><dc:creator>乔纳森·穆迪</dc:creator><dc:creator>纳卡诺（Masahiro Nakano）</dc:creator><dc:creator> Ziyue Chen</dc:creator><dc:creator> chi tian</dc:creator><dc:creator> Yuntian Zhang</dc:creator><dc:creator> Yihan Tong</dc:creator><dc:creator>晶体棕褐色</dc:creator><dc:creator>Anteneh Mehari Tizazu</dc:creator><dc:creator>玛丽·洛（Marie Loh）</dc:creator><dc:creator>你是黄</dc:creator><dc:creator>罗杰·乔</dc:creator><dc:creator>Anis Larbi</dc:creator><dc:creator> TZE PIN NG</dc:creator><dc:creator>洪赢了</dc:creator><dc:creator>弗雷德赖特</dc:creator><dc:creator>亚历山德拉 - 奇维拉尼</dc:creator><dc:creator>钟公园</dc:creator><dc:creator>穆里姆·崔（Murim Choi）</dc:creator><dc:creator> Boxiang Liu</dc:creator><dc:creator> Arindam Maitra</dc:creator><dc:creator> Manop Pithukpakorn</dc:creator><dc:creator> Bhoom Suktitipat</dc:creator><dc:creator> kazuyoshi ishigaki</dc:creator><dc:creator> Yukinori冈田</dc:creator><dc:creator>Yamamoto Kazuhiko</dc:creator><dc:creator>皮耶罗·卡宁奇</dc:creator><dc:creator>约翰·C·钱伯斯（John C Chambers）</dc:creator><dc:creator> Chung-chau Hon</dc:creator><dc:creator> Ponpan Matangkasombut</dc:creator><dc:creator> Varodom Charoensawan</dc:creator><dc:creator> Partha P Majumder</dc:creator><dc:creator>杰伊·W·辛（Jay W Shin）</dc:creator><dc:creator> Woong-Yang Park</dc:creator><dc:creator> Shyam Prabhakar</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>细胞</dc:source><dc:title>人类免疫细胞中的亚洲多样性</dc:title><dc:identifier>PMID：40112801</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.017</dc:identifier></item><item><title>巨型噬菌体杀手免疫系统靶向核形成噬菌体的早期感染</title><link/>https://pubmed.ncbi.nlm.nih.gov/40112800/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description> ϕKZ样家族的巨型细菌在感染过程中组装了基于脂质的早期噬菌体感染（EPI）囊泡和蛋白质核状结构。噬菌体，抑制早期的噬菌体基因并防止噬菌体... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月18<b>日</b>：0092-8674（25）00201-6。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> ϕKZ样家族的巨型细菌在感染过程中组装了基于脂质的早期噬菌体感染（EPI）囊泡和蛋白质核状结构。噬菌体，抑制早期的噬菌体基因和噬菌体的复制和噬菌体组装，同时保存细胞（以前是Yaaw）。在细菌的门中发现了与潜水员作用相关的细菌。这些发现揭示了一个广泛的防御系统，该系统专门针对噬菌体核组装之前由ϕkz样巨型噬菌体执行的早期事件。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40112800/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40112800</a> <a href=https://doi.org/10.1016/j.cell.2025.02.016>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40112800</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Li Yuping</dc:creator><dc:creator>林林关</dc:creator><dc:creator>伊莎贝尔·贝克</dc:creator><dc:creator>基拉·马卡罗娃（Kira S Makarova）</dc:creator><dc:creator> Xueli Cao</dc:creator><dc:creator> Surabhi Hareendranath</dc:creator><dc:creator> Jingwen Guan</dc:creator><dc:creator>弗兰克·斯坦</dc:creator><dc:creator>杨阳</dc:creator><dc:creator>Arne Boergel</dc:creator><dc:creator>卡琳·拉普格（Karine Lapouge）</dc:creator><dc:creator>金·雷曼斯（Kim Remans）</dc:creator><dc:creator>大卫·阿加德（David Agard）</dc:creator><dc:creator> Mikhail Savitski</dc:creator><dc:creator> Athanasios错别字</dc:creator><dc:creator>Eugene V Koonin</dc:creator><dc:creator> Yue Feng</dc:creator><dc:creator>约瑟夫·邦迪（Joseph Bondy）脱瘤</dc:creator><dc:date>2025-03-20</dc:date><dc:source>细胞</dc:source><dc:title>巨型噬菌体杀手免疫系统靶向核形成噬菌体的早期感染</dc:title><dc:identifier>PMID：40112800</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.016</dc:identifier></item><item><title>加速胰岛素mRNA衰减产生的1型糖尿病的遗传保护</title><link/>https://pubmed.ncbi.nlm.nih.gov/40112799/？ 08114047＆ff = 202503211054＆v = 2.18.0.post9+e462414<description>胰岛素基因（INS）变异和β细胞应力与1型糖尿病（T1D）的发展风险和针对胰岛素的自身免疫性。存在于携带SNP RS3842752的胰岛素mRNA中（g>; a）与... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月11日，<b>牢房</b>：0092-8674（25）00206-5：10.1016/j.cell.2025.02.018。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">胰岛素基因（INS）变异和β细胞应力与1型糖尿病（T1D）的发展风险和针对胰岛素的自身免疫性。存在于携带SNP RS3842752的胰岛素mRNA中（g>; a）与T1D保护的3&#39;未经翻译区域（INS <sup>P</sup> ）<sup>相关</sup>的beta电池会导致胰岛素mRNA衰变与<sup>易感性</sup>变体<sup>相比</sup>，胰岛素mRNA衰变与易于疾病的疾病相比，与<sup>糖尿病</sup><sup>相比</sup>，较少的ER应力和滴水新抗原。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40112799/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40112799</a> <a href=https://doi.org/10.1016/j.cell.2025.02.018>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40112799</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> RenéVanTienhoven</dc:creator><dc:creator>丹尼斯·奥真的</dc:creator><dc:creator>特里斯坦是斯科特</dc:creator><dc:creator>凯文诉莫里斯</dc:creator><dc:creator>约翰·威廉姆斯</dc:creator><dc:creator>约翰·卡迪斯（John S Kaddis）</dc:creator><dc:creator> Arnaud Zaldumbide</dc:creator><dc:creator> BART O ROEP</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>细胞</dc:source><dc:title>加速胰岛素mRNA衰减产生的1型糖尿病的遗传保护</dc:title><dc:identifier>PMID：40112799</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.018</dc:identifier></item><item><title> ICU研究中的心脏病患者：紧急呼吁包容</title><link/>https://pubmed.ncbi.nlm.nih.gov/40112166/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Cardiovasc Care。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID <a href=https://doi.org/10.1093/ehjacc/zuaf042>：</a> <a href="https://pubmed.ncbi.nlm.nih.gov/40112166/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40112166</a> |</p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40112166</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator>史蒂文·M·霍伦伯格（Steven M Hollenberg）</dc:creator><dc:creator>约瑟夫·帕里洛（Joseph E Parrillo）</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>ICU研究中的心脏病患者：紧急呼吁包容</dc:title><dc:identifier>PMID：40112166</dc:identifier><dc:identifier> doi：10.1093/ehjacc/zuaf042</dc:identifier></item><item><title>非侵入性地预测舒张期左心压曲线：回声可以走多远？</title><link/> https://pubmed.ncbi.nlm.nih.gov/40112160/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur J Cardiovasc成像。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID <a href=https://doi.org/10.1093/ehjci/jeaf088>：</a> <a href="https://pubmed.ncbi.nlm.nih.gov/40112160/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40112160</a> |</p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40112160</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator>弗兰克·弗拉克斯坎普</dc:creator><dc:creator>詹姆斯·托马斯（James D Thomas）</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>非侵入性地预测舒张期左心压曲线：回声可以走多远？</dc:title><dc:identifier> PMID：40112160</dc:identifier><dc:identifier> doi：10.1093/ehjci/jeaf088</dc:identifier></item><item><title>更好的是：放射科医生和心脏病专家共享的心血管成像中联合计划的果实</title><link/>https://pubmed.ncbi.nlm.nih.gov/40112028/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025 3月20日：ehae918。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40112028/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40112028</a> <a href=https://doi.org/10.1093/eurheartj/ehae918>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40112028</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Marcelo f di carli</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>更好的是：放射科医生和心脏病专家共享的心血管成像中联合计划的果实</dc:title><dc:identifier>PMID：40112028</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehae918</dc:identifier></item><item><title>从数据到感知：可视化人工智能生成图像中的偏见</title><link/>https://pubmed.ncbi.nlm.nih.gov/40111464/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025 3月20日：Ehae850：10.1093/Eurheartj/ehae850。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID <a href=https://doi.org/10.1093/eurheartj/ehae850>：</a> <a href="https://pubmed.ncbi.nlm.nih.gov/40111464/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40111464</a> |</p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40111464</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> PiotrSzymański</dc:creator><dc:creator> MagdalenaLipczyńska</dc:creator><dc:creator>安娜·玛丽亚·戈尔斯卡（AnnaMariaGórska）</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>从数据到感知：可视化人工智能生成图像中的偏见</dc:title><dc:identifier>PMID：40111464</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehae850</dc:identifier></item><item><title>认识团队：新EHJ编辑Rosa Maria Bruno，Mattia Galli和Mouaz Al-Mallah</title><link/> https://pubmed.ncbi.nlm.nih.gov/40111461/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025 3月20日：Ehae893：10.1093/Eurheartj/ehae893。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID <a href=https://doi.org/10.1093/eurheartj/ehae893>：</a> <a href="https://pubmed.ncbi.nlm.nih.gov/40111461/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40111461</a> |</p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40111461</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator>朱迪思·奥兹坎（Judith Ozkan）</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>认识团队：新EHJ编辑Rosa Maria Bruno，Mattia Galli和Mouaz Al-Mallah</dc:title><dc:identifier> PMID：40111461</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehae893</dc:identifier></item><item><title>缺血性心肌病和功能性二尖瓣反流的性心脏重塑的性别差异：对预后的影响</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110340/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description>结论：由于LV大小和FMR严重程度增加的女性表现出明显增加的不良结果风险，因此我们的发现表明，在ICM环境中，在FMR的热管理中得出了性别特异性CMR选择标准的重要性。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR J Imaging Methods实践。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Sex differences in prognosis of functional mitral regurgitation (FMR) associated with ischaemic cardiomyopathy (ICM) demonstrate the need to identify sex differences in cardiac remodelling. This study aimed to characterize sex differences in cardiac remodelling associated with FMR in the setting of ICM, sex interactions with cardiac remodelling and FMR severity, and predictors of all-cause mortality or heart transplantation using cardiac magnetic resonance (CMR)成像。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：审查了2002年至2017年之间CMR的连续患者，对790名患者进行了审查。在女性和男性中，先前的冠状动脉相似（所有<i>p</i> >; 0.05）。男性中的左心室和右心（LV和RV）的体积较大（所有比较<i>P</i> &lt;OR = 0.005），在FMR中，在<i>p</i> >; 0.0的情况下，LV和RV的相似性相似。 （ <i>p</i> = 0.696），调整FMR后严重性。调整医疗风险因素和CMR程序后的干预措施，女性表现出lv量增加的主要临床复合点的风险[危险比：1.04（95％置信区间：1.01-1.06）， <i>p</i> = 0.034]。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：由于LV大小和FMR严重程度增加的女性表现出明显增加的不良结果风险，因此我们的发现表明，在ICM环境中，在FMR的热管理中得出了性别特异性CMR选择标准的重要性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110340/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110340</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11920871/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11920871</a> <a href=https://doi.org/10.1093/ehjimp/qyaf021>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110340</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Duygu Kocyigit Bunkaya</dc:creator><dc:creator>南希是奥布乔夫斯基</dc:creator><dc:creator>娜塔莉·胡</dc:creator><dc:creator>Zoran B Popovic</dc:creator><dc:creator>大卫·陈（David Chen）</dc:creator><dc:creator>克里斯托弗·恩格恩（Christopher Nguyen）</dc:creator><dc:creator> WH WILSON TANG</dc:creator><dc:creator> Deborah H Kwon</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏杂志。</dc:source><dc:title>缺血性心肌病和功能性二尖瓣反流的性心脏重塑的性别差异：对预后的影响</dc:title><dc:identifier>PMID：40110340</dc:identifier><dc:identifier> PMC：PMC11920871</dc:identifier><dc:identifier> doi：10.1093/ehjimp/qyaf021</dc:identifier></item><item><title>基于物联网的系统对心脏康复监测的功效：心力衰竭患者的Inteliot Pivotal试验的见解</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110225/？ 08114047＆ff = 202503211054＆v = 2.18.0.post9+e462414<description>结论：基于物联网的医疗保健构成了HF患者的康复方法，而老年患者可能构成最有可能受益的人群。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur J Digit Health。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：针对远程临床监测的数字健康解决方案在心血管护理中不断获得基础。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：参加了临床稳定的HF患者，其中包括12个月的护理标准跑步阶段和相同持续时间的远程后续阶段，从而提供了基于IoT的E-Health System，以研究设备衍生的数据传播。 （ii）依从性使用的率及其与关键的临床参数的关联，（ii）体育活动的变化程度，（iii）医生专用于患者的护理，而没有E-Health Seption的帮助，则在每日阶段的情况下均与23.34％相关联。在对系统使用的年龄和渐进式下水效率之间观察到（ <i>r</i> = -0.5722， <i>p</i> = 0.02）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：基于物联网的医疗保健构成了HF患者的康复方法，而老年患者可能构成最有可能受益的人群。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110225/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110225</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914715/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914715</a> <a href=https://doi.org/10.1093/ehjdh/ztae093>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110225</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Maria E Marketou</dc:creator><dc:creator> ioannis anastasiou</dc:creator><dc:creator> Alexis Fourlis</dc:creator><dc:creator>阿芙罗狄蒂的阿维扎基</dc:creator><dc:creator>乔治·高克亚达克斯</dc:creator><dc:date>2025-03-20</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>基于物联网的系统对心脏康复监测的功效：心力衰竭患者的Inteliot Pivotal试验的见解</dc:title><dc:identifier>PMID：40110225</dc:identifier><dc:identifier> PMC：PMC11914715</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ztae093</dc:identifier></item><item><title>人工智能分析冠状动脉内光学相干断层扫描图像：系统评价</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110224/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description>冠状动脉连贯性层析成像（OCT）是围围冠状动脉的冠状动脉冠状动脉的指导，是对冠状动脉的冠状动脉的指导，而对支架的评估则是挑战性的。图像解释，牌匾... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR J Digit Health。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">冠状动脉连贯性层析成像（OCT）是围围冠状动脉的冠状动脉冠状动脉的指导，是对冠状动脉的冠状动脉的指导，而对支架的评估则是挑战性的。图像解释，牌匾近年来，已经提出了许多用于这些目的的AI模型的临床事件预测。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110224/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110224</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914731/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914731</a> <a href=https://doi.org/10.1093/ehjdh/ztaf005>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110224</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Ruben GA Van der Waerden</dc:creator><dc:creator>里克·HJA Volleberg</dc:creator><dc:creator> Thijs J Luttikholt</dc:creator><dc:creator> Pierandrea Cancian</dc:creator><dc:creator> Joske L van der Zande</dc:creator><dc:creator> Gregg W Stone</dc:creator><dc:creator> Niels R Holm</dc:creator><dc:creator>埃尔文·吉迪（Elvin Kedhi）</dc:creator><dc:creator>哈维尔逃脱了</dc:creator><dc:creator>达里奥·佩莱格里尼（Dario Pellegrini）</dc:creator><dc:creator> Giulio guagliumi</dc:creator><dc:creator> Shamir R Mehta</dc:creator><dc:creator>纳塔利亚·皮尼拉（Natalia pinilla-echeverri）</dc:creator><dc:creator>劳尔·莫雷诺（RaúlMoreno）</dc:creator><dc:creator>洛伦兹·雷伯（LorenzRäber）</dc:creator><dc:creator> Tomasz Roleder</dc:creator><dc:creator> Bram van ginneken</dc:creator><dc:creator>克拉拉（Clara ISánchez）</dc:creator><dc:creator>伊万娜·伊古姆（IvanaIšgum）</dc:creator><dc:creator>尼尔斯·范罗伊（Niels van Royen）</dc:creator><dc:creator> Jos Thannhauser</dc:creator><dc:date> 2025-03-20</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>人工智能分析冠状动脉内光学相干断层扫描图像：系统评价</dc:title><dc:identifier>PMID：40110224</dc:identifier><dc:identifier> PMC：PMC11914731</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ZTAF005</dc:identifier></item><item><title>机器学习评分以预测心脏重症监护病房住院的患者的院内结果</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110223/？ 08114047＆ff = 202503211054＆v = 2.18.0.post9+e462414<description>结论：根据七个简单而快速的临床和超声心动图变量，在预测重症监护室的患者中，该新的ML得分是第一个在预测院内结果方面提高性能的情况。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur J Digit Health。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：尽管基于传统统计方法的某些分数可用于在心脏重症监护病房（CICUS）住院的患者中的风险分层，但机器学习的兴趣（ML）方法（ML）在该领域的风险分层的兴趣我们旨在建立一个ML模型，以预测在CICU中住院的患者中的托管内主要不良事件（MAE）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：2021年4月，一项涉及39个中心的国家前瞻性多中心包括进入CICU的所有连续患者其余中心用作1499名保守患者的外部验证（64±15岁，男性70％），在28个临床，生物学，ECG和Echocartiography中，有7种训练的训练率（ <i>N</i> = 8444）。 iver操作特征在曲线（AUROC）= 0.90下，精度重新计算= 0.57， <i>F</i> 1分数= <i>0.5</i> ]。 。机器学习评分在外部队列中还表现出色（AUROC = 0.88）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：根据七个简单而快速的临床和超声心动图变量，在预测重症监护室的患者中，该新的ML得分是第一个在预测院内结果方面提高性能的情况。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">试验注册：ClinicalTrials.gov标识符：NCT05063097。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40110223/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">4011023</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914730/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914730</a> <a href=https://doi.org/10.1093/ehjdh/ztae098>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40110223</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Orianne Weizman</dc:creator><dc:creator> Kenza Hamzi</dc:creator><dc:creator>帕特里克·亨利</dc:creator><dc:creator>Guillaume Schurtz</dc:creator><dc:creator>玛丽·豪格·莫罗（Marie Hauguel-Moreau）</dc:creator><dc:creator> Antonin Trimaille</dc:creator><dc:creator>马克·贝萨萨（Marc Bedossa）</dc:creator><dc:creator>让·克劳德·迪布（Jean Claude Dib）</dc:creator><dc:creator> Sabir Atto</dc:creator><dc:creator> Tanissia Boukertouta</dc:creator><dc:creator>弗兰克·博卡拉（Franck Boccara）</dc:creator><dc:creator> Thibaut Pommier</dc:creator><dc:creator> Pascal Lim</dc:creator><dc:creator>托马斯·博查顿</dc:creator><dc:creator>达米安·米什（Damien Millischer）</dc:creator><dc:creator> Benoit Merat</dc:creator><dc:creator> Fabien Picard</dc:creator><dc:creator>尼西姆·格林伯格（Nissim Grinberg）</dc:creator><dc:creator>大卫·苏尔曼（David Sulman）</dc:creator><dc:creator> Bastien Pasdeloup</dc:creator><dc:creator> Yassine El Ouahidi</dc:creator><dc:creator> TreçyGonçalves</dc:creator><dc:creator>埃里克·维卡特（Eric Vicaut）</dc:creator><dc:creator> Jean-Guillaume Dillinger</dc:creator><dc:creator> Solenn Toupin</dc:creator><dc:creator> ThéoPezel</dc:creator><dc:creator>瘾君子ICCU调查人员</dc:creator><dc:date>2025-03-20</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>机器学习评分以预测心脏重症监护病房住院的患者的院内结果</dc:title><dc:identifier>PMID：40110223</dc:identifier><dc:identifier> PMC：PMC11914730</dc:identifier><dc:identifier> doi：10.1093/ehjdh/ztae098</dc:identifier></item><item><title>基于Sinus Rhythm心电图和临床特征，用于预测房颤患者左心房低压区域的多模式人工智能算法：回顾性，多中心研究</title><link/>https://pubmed.ncbi.nlm.nih.gov/40110222/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description>结论：多模式AI算法集成了ECG图像和临床特征，它预测了与单独使用ECG和临床LVA评分相比，LVA具有更高准确度的LVA。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur J Digit Health。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：我们旨在开发一种能够准确预测基于心律纤维化患者窦性心电图（ECGS）的左心房低压区域（LVA）的算法（LVA）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：该研究包括1133例接受导管消融程序的患者，总共分析了基于人工智能的算法的1787个12个潜在的ECG图像。 model performance. Multicentre validation included 92 AF patients from five centres, with a total of 174 ECGs. The data obtained from the participants were split into training ( <i>n</i> = 906), validation ( <i>n</i> = 113), and test sets ( <i>n</i> = 114). Low-voltage areas were detected in 47.4% of all participants. Using ECG alone, the convolutional neural network (CNN) model achieved an area under the ROC curve (AUROC) of 0.704, outperforming both the DR-FLASH score (AUROC = 0.601) and the APPLE score (AUROC = 0.589). Two multimodal AI models, which integrated ECG images and clinical features, demonstrated higher diagnostic accuracy (AUROC 0.816 and 0.796 for the CNN-Multimodal and CNN-Random Forest-Multimodal models, respectively). Our models also performed well in the multicentre validation dataset (AUROC 0.711, 0.785, and 0.879 for the ECG alone, CNN-Multimodal, and CNN-Random Forest-Multimodal models, respectively). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: The multimodal AI algorithm, which integrated ECG images and clinical features, predicted the presence of LVAs with a higher degree of accuracy than ECG alone and the clinical LVA scores.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110222/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110222</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914728/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914728</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae095>10.1093/ehjdh/ztae095</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110222</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Yirao Tao</dc:creator><dc:creator> Deyun Zhang</dc:creator><dc:creator> Naidong Pang</dc:creator><dc:creator> Shijia Geng</dc:creator><dc:creator> Chen Tan</dc:creator><dc:creator> Ying Tian</dc:creator><dc:creator> Shenda Hong</dc:creator><dc:creator> XingPeng Liu</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal. Digital health</dc:source><dc:title> Multi-modal artificial intelligence algorithm for the prediction of left atrial low-voltage areas in atrial fibrillation patient based on sinus rhythm electrocardiogram and clinical characteristics: a retrospective, multicentre study</dc:title><dc:identifier> pmid:40110222</dc:identifier><dc:identifier> pmc:PMC11914728</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae095</dc:identifier></item><item><title> A comparison of artificial intelligence-enhanced electrocardiography approaches for the prediction of time to mortality using electrocardiogram images</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110221/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description> CONCLUSION: Both the image 2D CNN and digitized 1D CNN enable mortality prediction from ECG images, with comparable performance to natively digital 1D CNN. Models trained on natively digital 1D ECGs can also be applied to digitized 1D ECGs, without any significant loss in performance. This work allows AI-ECG mortality prediction to be applied in diverse global settings lacking digital ECG infrastructure. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2024 Nov 18;6(2):180-189. doi: 10.1093/ehjdh/ztae090. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Most artificial intelligence-enhanced electrocardiogram (AI-ECG) models used to predict adverse events including death require that the ECGs be stored digitally. However, the majority of clinical facilities worldwide store ECGs as images. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: A total of 1 163 401 ECGs (189 539 patients) from a secondary care data set were available as both natively digital traces and PDF images. A digitization pipeline extracted signals from PDFs. Separate 1D convolutional neural network (CNN) models were trained on natively digital or digitized ECGs, with a discrete-time survival loss function to predict <i>time to mortality</i> . A 2D CNN model was trained on 310 × 868 px ECG images. External validation was performed in 958 954 ECGs (645 373 patients) from a Brazilian primary care cohort and 1022 ECGs (1022 patients) from a Chagas disease cohort. The image 2D CNN model and digitized 1D CNN model performed comparably to natively digital 1D CNN model in internal [C-index 0.780 (0.779-0.781), 0.772 (0.771-0.774), and 0.775 (0.774-0.776), respectively] and external validation. Models trained on natively digital 1D ECGs had comparable performance when applied to digitized 1D ECGs [C-index 0.773 (0.771-0.774)]. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: Both the image 2D CNN and digitized 1D CNN enable mortality prediction from ECG images, with comparable performance to natively digital 1D CNN. Models trained on natively digital 1D ECGs can also be applied to digitized 1D ECGs, without any significant loss in performance. This work allows AI-ECG mortality prediction to be applied in diverse global settings lacking digital ECG infrastructure.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110221/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110221</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914724/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914724</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae090>10.1093/ehjdh/ztae090</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110221</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Arunashis Sau</dc:creator><dc:creator> Boroumand Zeidaabadi</dc:creator><dc:creator> Konstantinos Patlatzoglou</dc:creator><dc:creator> Libor Pastika</dc:creator><dc:creator> Antônio H Ribeiro</dc:creator><dc:creator> Ester Sabino</dc:creator><dc:creator> Nicholas S Peters</dc:creator><dc:creator> Antonio Luiz P Ribeiro</dc:creator><dc:creator> Daniel B Kramer</dc:creator><dc:creator> Jonathan W Waks</dc:creator><dc:creator> Fu Siong Ng</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal. Digital health</dc:source><dc:title> A comparison of artificial intelligence-enhanced electrocardiography approaches for the prediction of time to mortality using electrocardiogram images</dc:title><dc:identifier> pmid:40110221</dc:identifier><dc:identifier> pmc:PMC11914724</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae090</dc:identifier></item><item><title> Comparison of machine learning and conventional criteria in detecting left ventricular hypertrophy and prognosis with electrocardiography</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110220/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description> CONCLUSION: Artificial intelligence-based LVH diagnosis outperformed conventional ECG criteria and was a superior predictor of mortality compared to echocardiography-confirmed LVH. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2025 Feb 11;6(2):252-260. doi: 10.1093/ehjdh/ztaf003. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Left ventricular hypertrophy (LVH) is clinically important; current electrocardiography (ECG) diagnostic criteria are inadequate for early detection. This study aimed to develop an artificial intelligence (AI)-based algorithm to improve the accuracy and prognostic value of ECG criteria for LVH detection. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: A total of 42 016 patients (64.3 ± 16.5 years, 55.3% male) were enrolled. LV mass index was calculated from echocardiographic measurements. Left ventricular hypertrophy screening utilized ECG criteria, including Sokolow-Lyon, Cornell product, Cornell/strain index, Framingham criterion, and Peguero-Lo Presti. An AI algorithm using CatBoost was developed and validated (training dataset 80% and testing dataset 20%). F1 scores, reflecting the harmonic mean of precision and recall, were calculated. Mortality data were obtained through linkage with the National Death Registry. The CatBoost-based AI algorithm outperformed conventional ECG criteria in detecting LVH, achieving superior sensitivity, specificity, positive predictive value, F1 score, and area under curve. Significant features to predict LVH involved QRS and P-wave morphology. During a median follow-up duration of 10.1 years, 1655 deaths occurred in the testing dataset. Cox regression analyses showed that LVH identified by AI algorithm (hazard ratio and 95% confidence interval: 1.587, 1.309-1.924), Sokolow-Lyon (1.19, 1.038-1.365), Cornell product (1.301, 1.124-1.505), Cornell/strain index (1.306, 1.185-1.439), Framingham criterion (1.174, 1.062-1.298), and echocardiography-confirmed LVH (1.124, 1.019-1.239) were all significantly associated with mortality. Notably, AI-diagnosed LVH was more predictive of mortality than echocardiography-confirmed LVH. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: Artificial intelligence-based LVH diagnosis outperformed conventional ECG criteria and was a superior predictor of mortality compared to echocardiography-confirmed LVH.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110220/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110220</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914727/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914727</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztaf003>10.1093/ehjdh/ztaf003</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110220</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Jui-Tzu Huang</dc:creator><dc:creator> Chih-Hsueh Tseng</dc:creator><dc:creator> Wei-Ming Huang</dc:creator><dc:creator> Wen-Chung Yu</dc:creator><dc:creator> Hao-Min Cheng</dc:creator><dc:creator> Hsi-Lu Chao</dc:creator><dc:creator> Chern-En Chiang</dc:creator><dc:creator> Chen-Huan Chen</dc:creator><dc:creator> Albert C Yang</dc:creator><dc:creator> Shih-Hsien Sung</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal. Digital health</dc:source><dc:title> Comparison of machine learning and conventional criteria in detecting left ventricular hypertrophy and prognosis with electrocardiography</dc:title><dc:identifier> pmid:40110220</dc:identifier><dc:identifier> pmc:PMC11914727</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztaf003</dc:identifier></item><item><title> Sudden cardiac arrest prediction via deep learning electrocardiogram analysis</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110219/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description> CONCLUSION: Deep learning models processing ECG data are a promising means of screening for SCA, and this method explains differences in SCAs due to age and sex. Model performance improved when ECGs were nearer in time to SCAs, although ECG data up to a year prior had predictive value. Sudden cardiac arrest prediction was more dependent upon QRS complex data compared to other ECG segments. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2025 Feb 25;6(2):170-179. doi: 10.1093/ehjdh/ztae088. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Sudden cardiac arrest (SCA) is a commonly fatal event that often occurs without prior indications. To improve outcomes and enable preventative strategies, the electrocardiogram (ECG) in conjunction with deep learning was explored as a potential screening tool. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: A publicly available data set containing 10 s of 12-lead ECGs from individuals who did and did not have an SCA, information about time from ECG to arrest, and age and sex was utilized for analysis to individually predict SCA or not using deep convolution neural network models. The base model that included age and sex, ECGs within 1 day prior to arrest, and data sampled from windows of 720 ms around the R-waves from 221 individuals with SCA and 1046 controls had an area under the receiver operating characteristic curve of 0.77. With sensitivity set at 95%, base model specificity was 31%, which is not clinically applicable. Gradient-weighted class activation mapping showed that the model mostly relied on the QRS complex to make predictions. However, models with ECGs recorded between 1 day to 1 month and 1 month to 1 year prior to arrest demonstrated predictive capabilities. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: Deep learning models processing ECG data are a promising means of screening for SCA, and this method explains differences in SCAs due to age and sex. Model performance improved when ECGs were nearer in time to SCAs, although ECG data up to a year prior had predictive value. Sudden cardiac arrest prediction was more dependent upon QRS complex data compared to other ECG segments.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110219/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110219</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914729/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914729</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae088>10.1093/ehjdh/ztae088</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110219</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Matt T Oberdier</dc:creator><dc:creator> Luca Neri</dc:creator><dc:creator> Alessandro Orro</dc:creator><dc:creator> Richard T Carrick</dc:creator><dc:creator> Marco S Nobile</dc:creator><dc:creator> Sujai Jaipalli</dc:creator><dc:creator> Mariam Khan</dc:creator><dc:creator> Stefano Diciotti</dc:creator><dc:creator> Claudio Borghi</dc:creator><dc:creator> Henry R Halperin</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal. Digital health</dc:source><dc:title> Sudden cardiac arrest prediction via deep learning electrocardiogram analysis</dc:title><dc:identifier> pmid:40110219</dc:identifier><dc:identifier> pmc:PMC11914729</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae088</dc:identifier></item><item><title> Interpretable predictive value of including HDL-2b and HDL-3 in an explainable boosting machine model for multiclass classification of coronary artery stenosis severity in acute myocardial infarction patients</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110218/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description> CONCLUSION: HDL-3 provides superior predictive value for evaluating coronary artery stenosis severity in AMI patients compared to HDL-2b and other conventional lipid markers. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2024 Dec 23;6(2):228-239. doi: 10.1093/ehjdh/ztae100. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: The aim of this study was to use explainable boosting machine (EBM) to evaluate the predictive value of HDL-2b and HDL-3 levels in comparison with traditional lipid parameters in three-class classification of coronary artery stenosis severity in acute myocardial infarction (AMI) patients. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: In this cross-sectional study, 1200 AMI patients were evaluated. HDL subtypes were quantified via microfluidic chip detection, and stenosis severity was assessed via the Gensini scoring system. The Gensini scores were divided into three groups: low group (&lt;36.5), moderate group (36.5-72), and high group (>;72). Explainable boosting machine, an interpretable machine learning technique, was employed to assess the predictive value of HDL-2b and HDL-3 compared with traditional lipid markers. Explainable boosting machine was used as the main model in this study, whereas logistic regression, XGBoost, and Random Forest were selected as reference models for predictive performance. Model performance was evaluated using receiver operating characteristic curves. The HDL-3 (%) values were divided into three risk categories: low (>;43), moderate (30-43), and high (&lt;30). The incorporation of HDL-2b and HDL-3 levels into lipid profiling significantly increased the group importance scores. The macro-average area under the curve values for the four models were as follows: 0.56 for the logistic model, 0.54 for the EBM model, 0.50 for the Random Forest model, and 0.49 for the XGBoost model. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: HDL-3 provides superior predictive value for evaluating coronary artery stenosis severity in AMI patients compared to HDL-2b and other conventional lipid markers.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110218/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110218</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914717/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914717</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae100>10.1093/ehjdh/ztae100</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110218</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Bin Wang</dc:creator><dc:creator> Dong Li</dc:creator><dc:creator> Yu Geng</dc:creator><dc:creator> Feifei Jin</dc:creator><dc:creator> Yujie Wang</dc:creator><dc:creator> Changhua Lv</dc:creator><dc:creator> Tingting Lv</dc:creator><dc:creator> Yajun Xue</dc:creator><dc:creator> Ping Zhang</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal. Digital health</dc:source><dc:title> Interpretable predictive value of including HDL-2b and HDL-3 in an explainable boosting machine model for multiclass classification of coronary artery stenosis severity in acute myocardial infarction patients</dc:title><dc:identifier> pmid:40110218</dc:identifier><dc:identifier> pmc:PMC11914717</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae100</dc:identifier></item><item><title> Machine learning-based scoring system to predict cardiogenic shock in acute coronary syndrome</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110217/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description> CONCLUSION: STOP SHOCK score is a simple ML-based tool available at first medical contact showing high performance for prediction of developing CS during hospitalization in ACS patients. The web application is available at https://stopshock.org/#calculator. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2025 Jan 6;6(2):240-251. doi: 10.1093/ehjdh/ztaf002. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Cardiogenic shock (CS) is a severe complication of acute coronary syndrome (ACS) with mortality rates approaching 50%. The ability to identify high-risk patients prior to the development of CS may allow for pre-emptive measures to prevent the development of CS. The objective was to derive and externally validate a simple, machine learning (ML)-based scoring system using variables readily available at first medical contact to predict the risk of developing CS during hospitalization in patients with ACS. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: Observational multicentre study on ACS patients hospitalized at intensive care units. Derivation cohort included over 40 000 patients from Beth Israel Deaconess Medical Center, Boston, USA. Validation cohort included 5123 patients from the Sheba Medical Center, Ramat Gan, Israel. The final derivation cohort consisted of 3228 and the final validation cohort of 4904 ACS patients without CS at hospital admission. Development of CS was adjudicated manually based on the patients&#39; reports. From nine ML models based on 13 variables (heart rate, respiratory rate, oxygen saturation, blood glucose level, systolic blood pressure, age, sex, shock index, heart rhythm, type of ACS, history of hypertension, congestive heart failure, and hypercholesterolaemia), logistic regression with elastic net regularization had the highest externally validated predictive performance ( <i>c</i> -statistics: 0.844, 95% CI, 0.841-0.847). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: STOP SHOCK score is a simple ML-based tool available at first medical contact showing high performance for prediction of developing CS during hospitalization in ACS patients. The web application is available at https://stopshock.org/#calculator.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110217/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110217</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914733/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914733</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztaf002>10.1093/ehjdh/ztaf002</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110217</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Allan Böhm</dc:creator><dc:creator> Amitai Segev</dc:creator><dc:creator> Nikola Jajcay</dc:creator><dc:creator> Konstantin A Krychtiuk</dc:creator><dc:creator> Guido Tavazzi</dc:creator><dc:creator> Michael Spartalis</dc:creator><dc:creator> Marta Kollarova</dc:creator><dc:creator> Imrich Berta</dc:creator><dc:creator> Jana Jankova</dc:creator><dc:creator> Frederico Guerra</dc:creator><dc:creator> Edita Pogran</dc:creator><dc:creator> Andrej Remak</dc:creator><dc:creator> Milana Jarakovic</dc:creator><dc:creator> Viera Sebenova Jerigova</dc:creator><dc:creator> Katarina Petrikova</dc:creator><dc:creator> Shlomi Matetzky</dc:creator><dc:creator> Carsten Skurk</dc:creator><dc:creator> Kurt Huber</dc:creator><dc:creator> Branislav Bezak</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal. Digital health</dc:source><dc:title> Machine learning-based scoring system to predict cardiogenic shock in acute coronary syndrome</dc:title><dc:identifier> pmid:40110217</dc:identifier><dc:identifier> pmc:PMC11914733</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztaf002</dc:identifier></item><item><title> Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology</title><link/> https://pubmed.ncbi.nlm.nih.gov/40110216/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250321101054&amp;v=2.18.0.post9+e462414<description> CONCLUSION: Mobile/wearable digital devices are considered to play an important role in different settings of cardio-oncology, including monitoring of patients&#39; parameters and arrhythmia detection. Their role in monitoring physical activity and QTc interval appears more nuanced. The most important perceived barrier to mobile/wearable digital device implementation is considered their high cost. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J Digit Health. 2025 Jan 21;6(2):162-169. doi: 10.1093/ehjdh/ztae082. eCollection 2025 Mar.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: The Council of Cardio-Oncology of the European Society of Cardiology developed an on-line anonymous survey to provide an overall picture of the current practice on the use of mobile and wearable digital devices in cardio-oncology and the potential barriers to their large-scale applicability. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: Between June 2023 and January 2024, an online anonymous questionnaire was completed by 220 healthcare professionals from 55 countries. The greatest number of respondents reported that mobile/wearable digital devices have a role in all active cancer patients for measuring heart rate (33.9%), blood pressure (34.4%), body temperature (32.0%), physical activity (42.4%), and sleep (31.2%). In the setting of atrial fibrillation detection, respondents were evenly split between applying these technologies in all patients (33.0%) or only in selected patients (33.0%). Regarding QTc interval monitoring, 30.6% reported that mobile/wearable digital devices play a role only in selected patients. The decision to use the device was taken by the patient in 56.6% of cases and the physician in 43.4%. The most important barrier reported to mobile/wearable device implementation in the setting of cardiac rhythm monitoring and QTc measurement was their cost (weighted average: 3.38 and 3.39, respectively). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: Mobile/wearable digital devices are considered to play an important role in different settings of cardio-oncology, including monitoring of patients&#39; parameters and arrhythmia detection. Their role in monitoring physical activity and QTc interval appears more nuanced. The most important perceived barrier to mobile/wearable digital device implementation is considered their high cost.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40110216/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">40110216</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914721/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250321101054&v=2.18.0.post9+e462414">PMC11914721</a> | DOI: <a href=https://doi.org/10.1093/ehjdh/ztae082>10.1093/ehjdh/ztae082</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40110216</guid><pubDate> Thu, 20 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Giuseppe Boriani</dc:creator><dc:creator> Jacopo F Imberti</dc:creator><dc:creator> Riccardo Asteggiano</dc:creator><dc:creator> Pietro Ameri</dc:creator><dc:creator> Davide A Mei</dc:creator><dc:creator> Michał Farkowski</dc:creator><dc:creator> Julian Chun</dc:creator><dc:creator> Josè Luis Merino</dc:creator><dc:creator> Teresa Lopez-Fernandez</dc:creator><dc:creator> Alexander R Lyon</dc:creator><dc:date> 2025-03-20</dc:date><dc:source> European heart journal. Digital health</dc:source><dc:title> Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology</dc:title><dc:identifier> pmid:40110216</dc:identifier><dc:identifier> pmc:PMC11914721</dc:identifier><dc:identifier> doi:10.1093/ehjdh/ztae082</dc:identifier></item></channel></rss>